146 related articles for article (PubMed ID: 38175384)
1. Development and Validation of a Prognostic Model for Postoperative Anastomotic Recurrence in Siewert II or III Adenocarcinomas Without Neoadjuvant Therapy in an East Asian Population.
Huang MB; Xu C; Chen H; Lin JX; Zheng CH; Chen QX; Lian MQ; Lian MJ; Lv CB; Yang SB; Cai LS; Huang CM; Xue FQ
J Gastrointest Cancer; 2024 Jan; ():. PubMed ID: 38175384
[TBL] [Abstract][Full Text] [Related]
2. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
3. Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery.
Guo Z; Guo H; Tian Y; Zhang Z; Zhao Q
Front Oncol; 2022; 12():908229. PubMed ID: 35756688
[TBL] [Abstract][Full Text] [Related]
4. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
[No Abstract] [Full Text] [Related]
5. [Comparison of efficacy between laparoscopic and open proximal gastrectomy with double-tract reconstruction for Siewert type Ⅱ and Ⅲ adenocarcinoma of the esophagogastric junction].
Ma F; Peng LQ; Liu CP; Zhang YL; Wang L; Zhang B; Ma Q; Ji SQ; Chai JH; Tang XC; Zhao EJ; Hua YW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):420-425. PubMed ID: 34000771
[No Abstract] [Full Text] [Related]
6. Development and validation of a nomogram for Siewert II esophagogastric junction adenocarcinoma: a retrospective analysis.
Jin T; Li ZD; Chen ZH; He FJ; Chen ZW; Liang PP; Hu JK; Yang K
Ther Adv Med Oncol; 2024; 16():17588359241229425. PubMed ID: 38322753
[TBL] [Abstract][Full Text] [Related]
7. Prognostic nomogram for Siewert type II adenocarcinoma of the esophagogastric junction patients with and without neoadjuvant radiotherapy: a retrospective cohort study.
Guo Z; Wang N; Liu F; Zhao Q
Am J Transl Res; 2022; 14(1):135-149. PubMed ID: 35173834
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
Chen J; Xia YJ; Liu TY; Lai YH; Yu JS; Zhang TH; Ooi S; He YL
BMC Cancer; 2021 May; 21(1):532. PubMed ID: 33971833
[TBL] [Abstract][Full Text] [Related]
9. The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction.
Curtis NJ; Noble F; Bailey IS; Kelly JJ; Byrne JP; Underwood TJ
J Surg Oncol; 2014 Mar; 109(3):202-7. PubMed ID: 24243140
[TBL] [Abstract][Full Text] [Related]
10. Development and external validation of a nomogram predicting overall survival for Gastric adenocarcinoma patients with radical gastrectomy.
He Z; Lin F; Cheng T; Gao J; Wang H; Zhang Z; Deng X
Scand J Gastroenterol; 2024; 59(1):52-61. PubMed ID: 37632275
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach.
Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM
JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494
[TBL] [Abstract][Full Text] [Related]
13. [Modified mattress inversion suturing with double barbed sutures used for totally laparoscopic esophagojejunostomy overlap anastomosis after radical total gastrectomy].
Wang HS; Hu XS; Lin YJ; Chen YH; Lian L; Peng JS
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Sep; 25(9):812-818. PubMed ID: 36117373
[No Abstract] [Full Text] [Related]
14. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
[TBL] [Abstract][Full Text] [Related]
15. Safety and feasibility of total laparoscopic radical resection of Siewert type II gastroesophageal junction adenocarcinoma through the left diaphragm and left thoracic auxiliary hole.
Huang Y; Liu G; Wang X; Zhang Y; Zou G; Zhao Z; Cao Z; Zhao H; Yuan X; Zhang C
World J Surg Oncol; 2021 Mar; 19(1):73. PubMed ID: 33714262
[TBL] [Abstract][Full Text] [Related]
16. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography-based nomogram of Siewert type II/III adenocarcinoma of esophagogastric junction to predict response to docetaxel, oxaliplatin and S-1.
Zhou CQ; Gao D; Gui Y; Li NP; Guo WW; Zhou HY; Li R; Chen J; Zhang XM; Chen TW
World J Radiol; 2024 Jan; 16(1):9-19. PubMed ID: 38312347
[TBL] [Abstract][Full Text] [Related]
18. Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma.
Zheng H; Zhao Y; He Q; Hao H; Tian Y; Zou B; Jiang L; Qiu X; Zhou Y; Li Z; Xu Y; Zhao G; Xue F; Li S; Fu W; Li Y; Zhou X; Li Y; Zhu Z; Chen J; Xu Z; Cai L; Li E; Li H; Xie J; Zheng C; Lu J; Li P; Huang C
Gastric Cancer; 2021 Mar; 24(2):503-514. PubMed ID: 32915373
[TBL] [Abstract][Full Text] [Related]
19. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
20. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
Mitchell KG; Ikoma N; Nelson DB; Maru DM; Erasmus JJ; Weston BR; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Swisher SG; Sepesi B; Walsh GL; Correa AM; Das P; Blum MA; Badgwell BD; Hofstetter WL
Ann Thorac Surg; 2019 Sep; 108(3):845-851. PubMed ID: 31102632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
